Blog Posts

Exclusive

Federal 340B Leader Moves On After 21 Months

Lt. Cmdr. Emeka Egwim headshot
U.S. Public Health Service Lieutenant Commander Emeka Egwim left his position as director of OPA at HRSA 21 months after he started.
U.S. Public Health Service Lieutenant Commander Emeka Egwim left his position as director of the federal office overseeing the 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

House Committee Approves PBM Transparency Bill with 340B Provision

The House E&C Committee on Dec. 6 unanimously approved a PBM transparency bill with a 340B program provision.
Lawmakers on a key House committee approved a pharmacy benefit manager (PBM) transparency bill on Wednesday that would require PBMs [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Unlocking Greater 340B Savings

SPONSORED CONTENT

The 340B program serves as a lifeline for many communities, allowing them to provide critical services to vulnerable, underserved patients. But unfortunately, the industry faces a spectrum of challenges, from mounting drug manufacturer restrictions to incomplete referral claims capture, which hinder a covered entity’s ability to optimize their 340B program.

To

Read More »

Amid Record Drugmaker Refunds, No Adverse Audit Findings for Teva

Teva
The final HRSA manufacturer 340B program audit conducted in fiscal year 2023 had no adverse findings for Teva Pharmaceuticals.
The fifth and final fiscal year 2023 manufacturer audit by federal officials recently concluded with no adverse findings. Meanwhile, the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Two Senior GOP Senators Suggest 340B Linked to Generic Drug Shortages

Sen. Mike Crapo (R-Idaho), ranking member of the Senate Finance Committee, said penny pricing under 340B warranted “serious scrutiny in the context of generic products.”
Two Republican Senators on an influential committee suggested during a hearing on Tuesday that 340B discounts could contribute to certain [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

New Part B Drug Claims Modifier Requirement for 340B Entities Starts Jan. 1

CMS
A CMS policy that requires 340B covered entities to use new Medicare Part B drug claims modifiers will take effect Jan. 1.
Critical access hospitals (CAHs) and Ryan White HIV/AIDS clinics do not expect problems implementing a new requirement starting Jan. 1, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Four 340B Terminations, Eight Paybacks to Manufacturers in Latest Provider Audit Findings

HRSA provider audits
Federal auditors issued termination sanctions for four covered entity sites or contract pharmacies.
Federal auditors determined terminations from the 340B program were required for either covered entity sites or contract pharmacies of four [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Biogen Adds Drug with Narrow Approval to 340B Contract Pharmacy Restrictions

Biogen wordmark on building facade
Drugmaker Biogen recently added a third drug to its 340B contract pharmacy restrictions for hospitals.
Biopharmaceutical manufacturer Biogen recently expanded its contract pharmacy restrictions for hospitals to a third drug, after that medication garnered a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Outlook from Capitol Hill, Federal Courts, and the States

SPONSORED CONTENT

Start your 340B Coalition Winter Conference ’24 with the latest developments in the 340B program with some of the most respected experts in the field. Verity Solutions will be hosting this lively panel discussion again where you will get an up-to-the-minute report on hot button topics

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report